NCT00934232View on ClinicalTrials.gov

Busulfan in Multiple Myeloma

PHASE1TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Multiple Myeloma
Interventions
DRUG

Busulfan

Busulfan (Bu) is a bifunctional alkylating agent currently used almost exclusively as a component of conditioning regimens for both autologous and allogeneic stem-cell transplants.

Sponsors

Lead Sponsor

Guido Tricot
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

lead

Guido Tricot

OTHER

NCT00934232 - Busulfan in Multiple Myeloma | Biotech Hunter | Biotech Hunter